Skip to content

Observational Study for the Clinical Effect of Bronchoscopic Local Therapy in Patients with Acute Aggravation of Bronchiectasis (Observational Study in the Real World)

Observational Study for the Clinical Effect of Bronchoscopic Local Therapy in Patients with Acute Aggravation of Bronchiectasis (Observational Study in the Real World)

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022247
Enrollment
Unknown
Registered
2019-03-31
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchiectasis

Interventions

Local treatment group:Intraoperation of dexamethasone and gentamicin under tracheoscope + Basic treatment
Routine treatment group:Basic treatment

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Non-cystic fibrotic bronchiectasis confirmed by chest CT or HRCT; 2. To meet the diagnostic criteria for acute exacerbation of bronchiectasis, see Annex 3 for details. 3. Aged 18 years and above, male or female; 4. Accord with the indication of bronchoscopy without contraindication. 5. When fully informed of the purpose, method and possible discomfort of the test, consent and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The drug was administered with prednisolone or equivalent systemic corticosteroids for more than 14 days within 4 weeks before administration; 2. Patients allergic to dexamethasone and gentamicin; 3. Patients with malignant tumors; 4. Patients with tractive bronchiectasis, cystic pulmonary fibrosis, active pulmonary tuberculosis, fungal infection, active sarcoidosis, allergic bronchopulmonary aspergillosis (ABPA), acute attack of asthma, dry bronchiectasis and bronchiectasis have hemoptysis more than 100 ml per day, hypogammaglobulinemia or common variants. Immunodeficiency disease (CVID), bronchiectasis caused by foreign body inhalation; 4. Those with serious other systemic diseases and organ dysfunction; 5. Pregnancy, lactation, recent family planning and failure to take effective contraceptive measures.

Design outcomes

Primary

MeasureTime frame
Indicators of clinical efficacy;

Secondary

MeasureTime frame
Quality of life;Chest CT;Sputum culture;pulmonary function;

Countries

China

Contacts

Public ContactHuiping Li

Shanghai Pulmonary Hospital Tongji University, School of Medicine

liw2013@126.com+86 13817389991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026